REG - Flex Labs Inc. - Director / PDMR Shareholding

TP IcapAnnouncement

08/03/2024 08:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240308:nRSH0711Ga&default-theme=true

RNS Number : 0711G  Flex Labs Inc.  08 March 2024

8 March 2024

Flex Labs Inc

 

("Flex Labs" or the "Company")

 

Director / PDMR Shareholding

 

Flex Labs (AQSE: FLEX) announces that it has been notified of the following
transactions in ordinary shares in the Company undertaken by a person closely
associated with Mike Edwards (Executive Chairman), details of which are set
out in the notification below.

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them.

 

 1.  Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Supernova Digital Assets PLC
 2.  Reason for the Notification
 a)  Position/status                                              PCA to a PDMR (Mike Edwards, Executive Chairman)
 b)  Initial notification / Amendment                             Initial notification
 3.  Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         Flex Labs Inc
 b)  LEI                                                          98450075C56BCFB38260
 4.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the Financial instrument, type of instrument  Ordinary Shares
     Identification Code                                          CA33939R1073
 b)  Nature of the transaction                                    Sale of Ordinary Shares
 c)  Price(s) and volume(s)                                       Price(s)                        Volume(s)
                                                                  GBP 0.0655 per Ordinary Share   500,000 Ordinary Shares (27 February 2024)

                                                                  GBP 0.065 per Ordinary Share    25,000 Ordinary Shares (8 February 2024)

                                                                  GBP 0.066 per Ordinary Share    137,500 Ordinary Shares (18 January 2024)

                                                                  GBP 0.0665 per Ordinary Share   400,000 Ordinary Shares (10 January 2024)

                                                                  GBP 0.065 per Ordinary Share    175,000 Ordinary Shares   (27 December 2023)
 d)  Aggregated information:

     · Aggregated volume                                          1,237,500 Ordinary Shares

     · Price                                                      £81,425
 e)  Date of the transaction                                      27 December 2023; 10 and 18 January 2024; 8 and 27 February 2024
 f)  Place of the Transaction                                     Aquis Stock Exchange

d)

Aggregated information:

· Aggregated volume

· Price

 

1,237,500 Ordinary Shares

£81,425

e)

Date of the transaction

27 December 2023; 10 and 18 January 2024; 8 and 27 February 2024

f)

Place of the Transaction

Aquis Stock Exchange

 

The directors of Flex Labs Inc accept responsibility for this announcement.

 

For further information please contact:

 

 Flex Labs Inc

 Michael Edwards      Via First Sentinel

 First Sentinel (Corporate Adviser)

 Brian Stockbridge    brian@first-sentinel.com (mailto:brian@first-sentinel.com)

  

                      +44 (0) 20 3855 5551

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NEXQKOBPOBKDQNK